TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

Prithviraj Bose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.